Evidence map›Paper›PMID 39594686›Full record

ArticleCancers2024

Enhancing Survival Outcome Predictions in Metastatic Non-Small Cell Lung Cancer Through PET Radiomics Analysis.

Shuo Wang, Darryl Belemlilga, Yu Lei, Apar Kishor P Ganti, Chi Lin, Samia Asif, Jacob T Marasco, Kyuhak Oh, Sumin Zhou

Abstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shuo WangDepartment of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Darryl BelemlilgaDepartment of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Yu LeiDepartment of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE 68198, USA.ORCID 0000-0002-8067-3015
Apar Kishor P GantiDivision of Oncology and Hematology, Department of Internal Medicine, VA Nebraska Western Iowa Health Care System, Omaha, NE 68105, USA.ORCID 0000-0003-3724-2671
Chi LinDepartment of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Samia AsifDivision of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68105, USA.
Jacob T MarascoDepartment of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE 68198, USA.ORCID 0009-0001-5414-788X
Kyuhak OhDepartment of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Sumin ZhouDepartment of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE 68198, USA.

Funding

the Nebraska Tobacco Settlement Biomedical Research Development Fund (NTSBRDF) 3157210070
6 · The paper itself

Abstract

(1) Background: Advanced-stage lung cancer poses significant management challenges. The goal of this study was to identify crucial clinical and PET radiomics features that enable prognostic stratification for predicting outcomes. (2) Methods: PET radiomics features of the primary lung lesions were extracted from 99 patients with stage IVB NSCLC, and the robustness of these PET radiomics features was evaluated against uncertainties stemming from extraction parameters and contour variation. We trained three survival risk models (clinical, radiomics, and a composite) through a penalized Cox model framework. We also created a Balanced Random Forest classification predictive model, using the selected features, to predict 1-year survival. (3) Results: We identified 367 common PET radiomics features that exhibited robustness to perturbations introduced by contour variation and extraction parameters. Our findings indicated that both the radiomics and the composite model outperformed the clinical model in stratifying the risk for survival with statistical significance. In predicting 1-year survival, the radiomics model and the composite model also achieved better predicting accuracies compared to the clinical model. (4) Conclusions: Robust PET radiomics analysis successfully facilitated the stratification of patient risk for survival outcomes and predicted 1-year survival in stage IVB NSCLC.

Indexed as

non-small cell lung cancer (NSCLC)positron emission tomographyradiomics

Identifiers

PMID39594686
PMCPMC11592397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.